Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Dayang Biological Chemical is a publicly traded chemical manufacturer based in China that specializes in the production of inorganic salts and pharmaceutical intermediates. The company is a global leader in the potassium carbonate and potassium bicarbonate markets, providing essential materials for the food, pharmaceutical, and industrial sectors. In the life sciences arena, it is a significant producer of the veterinary anti-coccidial drug Amprolium Hydrochloride and various specialized fluorinated intermediates used in human drug synthesis. Listed on the Shenzhen Stock Exchange, the company operates large-scale manufacturing facilities and maintains a strong focus on research and development to support its diverse chemical portfolio. Its products are distributed globally, serving as a critical component in the agricultural and pharmaceutical supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Dayang.